95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.80%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-3.19%
Negative gross profit growth while AEM is at 8.28%. Joel Greenblatt would examine cost competitiveness or demand decline.
-3.19%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-3.19%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-278.54%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-284.62%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-284.62%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.06%
Share reduction more than 1.5x AEM's 0.82%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.06%
Diluted share reduction more than 1.5x AEM's 0.46%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-51.94%
Dividend reduction while AEM stands at 5.73%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-8.92%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-8.51%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
250.27%
Similar 10Y revenue/share CAGR to AEM's 246.31%. Walter Schloss might see both firms benefiting from the same long-term demand.
40.54%
Positive 5Y CAGR while AEM is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-16.83%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
417.66%
10Y OCF/share CAGR in line with AEM's 414.08%. Walter Schloss would see both as similarly efficient over the decade.
20.23%
Positive OCF/share growth while AEM is negative. John Neff might see a comparative advantage in operational cash viability.
-32.27%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-721.54%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-217.95%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-170.14%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
934.73%
10Y equity/share CAGR above 1.5x AEM's 224.34%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
86.95%
Positive 5Y equity/share CAGR while AEM is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
27.75%
Positive short-term equity growth while AEM is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-59.03%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-16.89%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
-3.73%
Negative asset growth while AEM invests at 0.83%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.85%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-9.51%
We’re deleveraging while AEM stands at 1.66%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-14.70%
We cut SG&A while AEM invests at 8.92%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.